Skip to Main Content
  • Search
    Close
  • Limited Partners
Essex Woodlands Health Ventures
  • About Us
  • Investment Strategy
  • Team
  • Portfolio
  • News
  • Contact Us

Chroma Therapeutics

Logo

Identifies novel anti-cancer agents that combine the efficacy of cytotoxics with the tumor cell selectivity of modern targeted therapeutics.

Abingdon, United Kingdom

Contact: Petri Vainio

www.chromatherapeutics.com

Related News

Chroma Therapeutics and Cell Therapeutics Enter into a Collaboration to Develop and Commercialise Tosedostat, a First in Class Tumour Selective Oral Anti-Cancer Therapy

Chroma Therapeutics Advances Novel Targeted Agent Into Development;  Receives Milestone Payment

GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs

Essex Woodlands   A growth equity and venture capital healthcare investor

  • Palo Alto
  • Houston
  • New York
  • London

All content © 2010 | Legal Disclaimer

Website by Eric Miller Design